Brief: Auris Medical Reaches Midpoint For Enrollment In Part B Of AM-125 Phase 2 Travers Trial In Acute Peripheral Vertigo

Altamira Therapeutics

14/05/2021 14:00

May 14 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL REACHES MIDPOINT FOR ENROLLMENT IN PART B OF
AM-125 PHASE 2 TRAVERS TRIAL IN ACUTE PERIPHERAL VERTIGO
    * AURIS MEDICAL HOLDING - IN PART B OF TRAVERS TRIAL,
COMPANY WILL
ENROLL 72 PATIENTS WHO SUFFER FROM ACUTE PERIPHERAL VERTIGO
FOLLOWING NEUROSURGERY
    * AURIS MEDICAL HOLDING LTD - EXPECTS TO COMPLETE ENROLLMENT
INTO
PART B OF TRAVERS TRIAL BY END OF Q3 2021

Source text for Eikon:  ID:nGNXbMqqjK 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))